BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26462884)

  • 21. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK.
    Huang Q; Wang T; Yang L; Wang HY
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice.
    Liu TY; Xiong XQ; Ren XS; Zhao MX; Shi CX; Wang JJ; Zhou YB; Zhang F; Han Y; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
    Diabetes; 2016 Nov; 65(11):3262-3275. PubMed ID: 27504012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress.
    Baena M; Sangüesa G; Hutter N; Sánchez RM; Roglans N; Laguna JC; Alegret M
    Biochim Biophys Acta; 2015 Feb; 1851(2):107-16. PubMed ID: 25463011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
    Clar J; Mutel E; Gri B; Creneguy A; Stefanutti A; Gaillard S; Ferry N; Beuf O; Mithieux G; Nguyen TH; Rajas F
    Hum Mol Genet; 2015 Apr; 24(8):2287-96. PubMed ID: 25561689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis.
    Zhang Y; Vasheghani F; Li YH; Blati M; Simeone K; Fahmi H; Lussier B; Roughley P; Lagares D; Pelletier JP; Martel-Pelletier J; Kapoor M
    Ann Rheum Dis; 2015 Jul; 74(7):1432-40. PubMed ID: 24651621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated Autophagy in Hepatocytes Promotes Bisphenol A-Induced Hepatic Lipid Accumulation in Male Mice.
    Yang S; Zhang A; Li T; Gao R; Peng C; Liu L; Cheng Q; Mei M; Song Y; Xiang X; Wu C; Xiao X; Li Q
    Endocrinology; 2017 Sep; 158(9):2799-2812. PubMed ID: 28323964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.
    Hoogerland JA; Peeks F; Hijmans BS; Wolters JC; Kooijman S; Bos T; Bleeker A; van Dijk TH; Wolters H; Gerding A; van Eunen K; Havinga R; Pronk ACM; Rensen PCN; Mithieux G; Rajas F; Kuipers F; Reijngoud DJ; Derks TGJ; Oosterveer MH
    J Inherit Metab Dis; 2021 Jul; 44(4):879-892. PubMed ID: 33739445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
    Kim GY; Lee YM; Kwon JH; Cho JH; Pan CJ; Starost MF; Mansfield BC; Chou JY
    Mol Genet Metab; 2017 Mar; 120(3):229-234. PubMed ID: 28096054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas.
    Mutel E; Abdul-Wahed A; Ramamonjisoa N; Stefanutti A; Houberdon I; Cavassila S; Pilleul F; Beuf O; Gautier-Stein A; Penhoat A; Mithieux G; Rajas F
    J Hepatol; 2011 Mar; 54(3):529-37. PubMed ID: 21109326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia.
    Zhang L; Lee C; Arnaoutova I; Anduaga J; Starost MF; Mansfield BC; Chou JY
    Biochem Biophys Res Commun; 2020 Jun; 527(3):824-830. PubMed ID: 32430177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells.
    Sinha RA; Singh BK; Zhou J; Xie S; Farah BL; Lesmana R; Ohba K; Tripathi M; Ghosh S; Hollenberg AN; Yen PM
    Autophagy; 2017 Jan; 13(1):169-186. PubMed ID: 27846372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tris (1, 3-dichloro-2-propyl) phosphate induces apoptosis and autophagy in SH-SY5Y cells: Involvement of ROS-mediated AMPK/mTOR/ULK1 pathways.
    Li R; Zhou P; Guo Y; Lee JS; Zhou B
    Food Chem Toxicol; 2017 Feb; 100():183-196. PubMed ID: 28025121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
    Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
    Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review.
    Cho JH; Weinstein DA; Lee YM
    J Inherit Metab Dis; 2021 Jan; 44(1):118-128. PubMed ID: 32474930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis.
    He Q; Mei D; Sha S; Fan S; Wang L; Dong M
    J Mol Endocrinol; 2016 Nov; 57(4):251-260. PubMed ID: 27658958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia.
    Lee YM; Pan CJ; Koeberl DD; Mansfield BC; Chou JY
    Mol Genet Metab; 2013 Nov; 110(3):275-80. PubMed ID: 23856420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.
    Chopra AR; Louet JF; Saha P; An J; Demayo F; Xu J; York B; Karpen S; Finegold M; Moore D; Chan L; Newgard CB; O'Malley BW
    Science; 2008 Nov; 322(5906):1395-9. PubMed ID: 19039140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage.
    Cho JH; Lee YM; Starost MF; Mansfield BC; Chou JY
    J Inherit Metab Dis; 2019 May; 42(3):459-469. PubMed ID: 30637773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.
    Sinha RA; Farah BL; Singh BK; Siddique MM; Li Y; Wu Y; Ilkayeva OR; Gooding J; Ching J; Zhou J; Martinez L; Xie S; Bay BH; Summers SA; Newgard CB; Yen PM
    Hepatology; 2014 Apr; 59(4):1366-80. PubMed ID: 23929677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway.
    Cai ZY; Yang B; Shi YX; Zhang WL; Liu F; Zhao W; Yang MW
    Biochem Biophys Res Commun; 2018 Sep; 503(2):428-435. PubMed ID: 29649480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.